ATE297409T1 - In krebszellen überexprimiertes genprodukt - Google Patents

In krebszellen überexprimiertes genprodukt

Info

Publication number
ATE297409T1
ATE297409T1 AT97948500T AT97948500T ATE297409T1 AT E297409 T1 ATE297409 T1 AT E297409T1 AT 97948500 T AT97948500 T AT 97948500T AT 97948500 T AT97948500 T AT 97948500T AT E297409 T1 ATE297409 T1 AT E297409T1
Authority
AT
Austria
Prior art keywords
cancer cells
gene product
product overexpressed
relates
overexpressed
Prior art date
Application number
AT97948500T
Other languages
English (en)
Inventor
Russel E Kaufman
Kimberly A Slentz-Kesler
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE297409T1 publication Critical patent/ATE297409T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97948500T 1996-11-22 1997-11-24 In krebszellen überexprimiertes genprodukt ATE297409T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/755,559 US5912142A (en) 1996-11-22 1996-11-22 Gene product over expressed in cancer cells
PCT/US1997/021517 WO1998022502A1 (en) 1996-11-22 1997-11-24 Gene product over expressed in cancer cells

Publications (1)

Publication Number Publication Date
ATE297409T1 true ATE297409T1 (de) 2005-06-15

Family

ID=25039660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948500T ATE297409T1 (de) 1996-11-22 1997-11-24 In krebszellen überexprimiertes genprodukt

Country Status (6)

Country Link
US (1) US5912142A (de)
EP (1) EP0960128B1 (de)
AT (1) ATE297409T1 (de)
AU (1) AU5455798A (de)
DE (1) DE69733491T2 (de)
WO (1) WO1998022502A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1183041A2 (de) 1999-05-28 2002-03-06 Immunex CorporatioN Cd7-ligand und verwendungen davon
US20050153402A1 (en) * 1999-06-25 2005-07-14 Basf Ag Corynebacterium glutamicum genes encoding regulatory proteins
AU2001249493A1 (en) * 2000-03-28 2001-10-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
AU2001274946A1 (en) * 2000-05-24 2001-12-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
CA2743891A1 (en) * 2009-04-14 2010-10-21 SOCPRA Sciences Sante et Humaines S.E.C. Signature of secreted protein isoforms specific to ovarian cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1370592A (en) * 1991-02-01 1992-09-07 Oncogene Science, Inc. Immunoassay for detection of mutant p53 polypeptide in biological fluids
DE69333202T2 (de) * 1992-06-26 2004-03-18 The Trustees Of Princeton University Verfahren zur erkennung von krebszellen oder ihren vorstadien mittels p90 und p53-antikörper oder p90 und p53-sonden
AU4544393A (en) * 1992-06-26 1994-01-24 Trustees Of Princeton University, The Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes
EP0652232B1 (de) * 1993-08-02 2003-10-29 Health Research, Inc. Protein P53as sowie Plasmide und virale Vektoren, die eine zu der das Protein codierende DNA-Sequenz komplementäre cDNA-Sequence enthalten
US5589358A (en) * 1993-12-29 1996-12-31 Univ Wake Forest Ileal bile acid transporter compositions and methods

Also Published As

Publication number Publication date
WO1998022502A1 (en) 1998-05-28
DE69733491D1 (de) 2005-07-14
DE69733491T2 (de) 2006-03-23
EP0960128A1 (de) 1999-12-01
AU5455798A (en) 1998-06-10
US5912142A (en) 1999-06-15
EP0960128A4 (de) 2001-03-14
EP0960128B1 (de) 2005-06-08

Similar Documents

Publication Publication Date Title
FI941572A0 (fi) Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
DK0858467T3 (da) Materialer og fremgangsmåder angående identifikationen og sekventeringen af BRCA2 cancerfölsomhedsgen og anvendelser deraf
EP0284362A3 (de) Molekulare Markierungen
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
NO975508L (no) DNA-sekvens og kodet bryst- spesifikt brystkreftprotein
ATE209680T1 (de) Isolierte nukleinsäuremoleküle, peptide die mit hla-a2 moleküle (mhc) komplexe bilden, sowie deren verwendungen
EP1126034A3 (de) Kodierende Sequenzen des menschlichen BRCA1-Gens
DE69131580D1 (de) GDF-1 und UOG1 Proteine
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
NZ510356A (en) Molecules designated LDCAM
MX9801264A (es) Control de la expresion del gen de cd44 para uso terapeutico.
FI970979A0 (fi) Muokatut ihmisen C3-proteiinit
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DK1536006T3 (da) Cancerantigener og anvendelse deraf
DE69733491D1 (de) In Krebszellen überexprimiertes Genprodukt
NZ510154A (en) A tumour antigen protein and gene therefor, tumour antigen peptides and derivatives thereof in medicaments and prophylactics
TR200101141T2 (tr) Antitümör etkiyi haiz antijenik proteini şifreleyen bir DNA'ya mahsus parçalar ihtiva eden farmasötik bileşim
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
BR9710919A (pt) Proteina purificada sr-p70
ATE364706T1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
WO2000040752A3 (en) Cancer associated genes and their products
NO179328C (no) Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom
SG148035A1 (en) Gene products differentially expressed in cancerous breast cells and their methods of use
UY26170A1 (es) Antigeno (c42) asociados a tumores

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties